Author Archive: Jim Lane

rss feed

Consolidation! Dyadic sells industrial technology biz to DuPont for $75M

Consolidation! Dyadic sells industrial technology biz to DuPont for $75M

November 11, 2015 |

As Dyadic cashes out of industrial biotech and retains a C1 license for pharma, DSM and Syngenta also announce a partnership. Companies are girding their loins for the long haul. The Digest takes a look, In Florida, DuPont Industrial Biosciences will acquire substantially all of the enzyme and technology assets Dyadic’s Industrial Technology business for $75 […]

Read More

Protected: ABLC Next 2015 presentations

Protected: ABLC Next 2015 presentations

November 11, 2015 |

There is no excerpt because this is a protected post.

Read More

Will boaters make Gevo rock?

Will boaters make Gevo rock?

November 10, 2015 |

Despite a signature partnership with Praj, Gevo’s short-term future looks strongest at the marina, where blockbuster economics apply. So Praj and Gevo, which began dating some time ago as prospective partners and started going steady a few months ago in signing an MOU — have decided to move in together, via a license agreement and […]

Read More

Digest Bioeconomy Index gains 1.49 percent to 54.66 as enzymes rock

Digest Bioeconomy Index gains 1.49 percent to 54.66 as enzymes rock

November 10, 2015 |

The Digest Bioeconomy Index, an index of publicly traded advanced bioeconomy stocks, rose 1.49 percent to 54.66 as enzymes rocked. For the day, Aemetis (AMTX) dumped 19.40 percent to $2.02, while Pacific Ethanol (PEIX) swooned 8.15 percent to $4.51. Among other equities, Dyadic (DYAI) soared 68.42 percent to $1.60 on news of a DuPont deal. […]

Read More

Bolt On, Tune Up, Drop In: The Sweet 16 Bolt-on bioeconomy technologies

Bolt On, Tune Up, Drop In: The Sweet 16 Bolt-on bioeconomy technologies

November 9, 2015 |

Read More

Digest Bioeconomy Index falls 1.55 percent to 53.86 as enzymes dip

Digest Bioeconomy Index falls 1.55 percent to 53.86 as enzymes dip

November 9, 2015 |

The Digest Bioeconomy Index, an index of publicly traded advanced bioeconomy stocks, fell 1.55 percent to  53.86 as enzymes dipped. For the day, Pacific Ethanol (PEIX) lost 6.65 percent to $4.91, while Abengoa (ABGB) rallied 9.38 percent to $5.83. Among other equities, Dyadic (DYAI) shed 5.00 percent to $0.95. Overall, declines led advances by a […]

Read More

The most astonishing biofuels comment that never happened

The most astonishing biofuels comment that never happened

November 8, 2015 |

Read More

General Relativity, and the remaking of Sweetwater Energy

General Relativity, and the remaking of Sweetwater Energy

November 8, 2015 |

Minnesota Awards $26 Million to Fund Sweetwater’s Biochemical Facility In Minnesota, Sweetwater Energy has received commitment for $26 million in long-term loans from the state of Minnesota to construct a biochemical production facility near Mountain Iron in northeastern Minnesota. The $53M facility will use local timber to produce high-value industrial alcohol and activated carbon. The […]

Read More

Carson, Clinton take Iowa in the Digest’s Mirror presidential election

Carson, Clinton take Iowa in the Digest’s Mirror presidential election

November 8, 2015 |

In the Digest’s Mirror US Presidential Election, focused on bioeconomy voters in the weeks leading up to the actual Iowa Caucuses, Ben Carson won the Iowa Republican caucuses and Hillary Clinton took the Iowa Democratic caucuses. In our winner-take all system, we have awarded 30 delgates to Ben Carson and 46 to Hillary Clinton. Complete […]

Read More

Digest Bioeconomy Index edges up 0.27 percent to  54.71 as chemical equities rally

Digest Bioeconomy Index edges up 0.27 percent to 54.71 as chemical equities rally

November 8, 2015 |

The Digest Bioeconomy Index, an index of publicly traded advanced bioeconomy stocks, edged up 0.27 percent to  54.71 as chemical equities rallied. For the day, Gevo (GEVO) dumped 10.94 percent to $1.71, while Aemetis (AMTX) dropped 6.94 percent to $2.62. Among other equities, Metabolix (MBLX) surged 12.01 percent to $2.61. Overall, advances led declines by […]

Read More